Efficacy of a new intravenous β2-adrenergic agonist (bedoradrine, MN-221) for patients with an acute exacerbation of asthma. [electronic resource]
Producer: 20160818Description: 1268-73 p. digitalISSN:- 1532-3064
- Acetamides -- administration & dosage
- Acute Disease
- Administration, Inhalation
- Administration, Intravenous
- Adrenergic beta-2 Receptor Agonists -- administration & dosage
- Adult
- Asthma -- drug therapy
- Bronchodilator Agents -- administration & dosage
- Double-Blind Method
- Dyspnea -- drug therapy
- Female
- Glucocorticoids -- administration & dosage
- Humans
- Ipratropium -- administration & dosage
- Male
- Middle Aged
- Naphthalenes -- administration & dosage
- Prednisone -- administration & dosage
- Prospective Studies
- Spirometry
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.